Piezo2-related Arthrogryposis study
Part of Bones, joints & muscles, Genetic & congenital clinical trials.
This study explores how a specific gene change (PIEZO2) affects people with arthrogryposis, a condition that causes joint stiffness. It may help researchers understand the disease better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a change in the PIEZO2 gene that makes it more active.
- You must be at least 10 years old.
- You must be enrolled in the PARART database, which tracks people with arthrogryposis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how changes (mutations) in a gene called ACTG2 affect the muscles that move food through the gut in children and adults with a rare condition called pediatric intestinal pseudo-obstruction (PIPO). It may help researchers understand the condition better and find new ways to help patients.
This study looks at people with Kosaki or Penttinen syndrome who have a specific genetic change in the PDGFRB gene. It aims to improve how these conditions are understood and treated, using information from participants who consent to the study.
This study looks at how nerves send signals in people with a rare genetic condition (PIEZO2) that affects touch and pain. It also enrolls healthy volunteers for comparison. Researchers will use a tiny needle to record nerve activity.
This study follows people with a confirmed PKP2 genetic mutation and arrhythmogenic cardiomyopathy (ACM) to understand how their condition changes over time. It may help doctors learn more about the disease and plan future treatments.
This study looks at how plakophilin 2 (PKP2)-related arrhythmogenic right ventricular cardiomyopathy (ARVC) progresses over time. You'll give blood samples to check for antibodies to a virus used in gene therapy, and help doctors understand the disease better.
This study looks at how psoriatic arthritis affects daily life and how that relates to disease activity. It may help researchers better understand the condition and improve care.
Hear when a new Arthrogryposis Multiplex Congenita trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.